Leadership


  • A photograph of a Sarepta building in Boston, MA
    Image attribution tooltip
    Courtesy of Sarepta
    Q&A

    For Duchenne-focused Sarepta, gene therapy is the natural next step

    The company with three marketed RNA drugs for Duchenne muscular dystrophy is taking the logical leap into gene therapies with a candidate under review at the FDA.

    By Dec. 8, 2022
  • Charlotte Owens, vice president, head of the Center for Health Equity and Patient Affairs, Takeda
    Image attribution tooltip
    Permission granted by Takeda
    Q&A

    Takeda’s global quest for health equity

    Takeda’s Center for Health Equity and Patient Affairs is built to address health inequality around the world and aims to raise the bar for the pharma industry.

    By Dec. 8, 2022
  • A man in a suit looking at the camera
    Image attribution tooltip
    Courtesy of Biogen

    10 noteworthy pharma leadership shake-ups this year

    From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.

    By Dec. 7, 2022
  • Beatrice McQueen WoW image
    Image attribution tooltip
    Permission granted by Beatrice McQueen
    Podcast

    Woman of the Week: Simcha Therapeutics’ Beatrice McQueen

    From sea sponges to cytokines, the chief operating officer’s career has come full circle as she pursues a new approach to treating cancer via the immune system.

    By Dec. 7, 2022
  • lightbulb breaking
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

    By Dec. 2, 2022
  • pills
    Image attribution tooltip
    Stock via Getty Images

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By Nov. 30, 2022
  • Alison O'Neill B&W head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Surface Oncology’s Dr. Alison O’Neill

    With more than two decades of experience in oncology R&D, Dr. Alison O’Neill is helping Surface unlock the potential of next-gen immunotherapies by targeting the tumor microenvironment.

    By Nov. 30, 2022
  • A team of four people wearing white lab coats stand looking at a computer in a medical science laboratory.
    Image attribution tooltip
    Stock via Getty Images

    One biotech’s approach to science-driven innovation

    Why some in the industry say fostering creativity in drug development is all about work structures.

    By Nov. 29, 2022
  • Barry Sherman
    Image attribution tooltip

    Al Dunlop/ZUMA Press/Newscom

    5 enduring mysteries of the Barry and Honey Sherman murders

    After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.

    By Nov. 28, 2022
  • Nicole Lambert WoW picture
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Myriad Genetics’ Nicole Lambert

    Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.

    By Nov. 23, 2022
  • A building showing a logo of Teva Pharmaceutical
    Image attribution tooltip
    Courtesy of Teva Pharmaceutical

    Executive changes at Teva, Eversana could spell commercial growth in the new year

    With their latest personnel moves, these life sciences companies are preparing for major business shifts.

    By Nov. 23, 2022
  • office red
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    Hybrid work is here to stay — here’s how leaders should adjust

    Executives across the life sciences share their tips for navigating the new norm of remote work.

    By Nov. 18, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By Nov. 11, 2022
  • Tier Bryant, 82VS
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: 82VS’s Trier Bryant

    Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Not every leader makes it their mission to go where the fire ...

    By Nov. 9, 2022
  • Gulden Mesera wow pix
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: City of Hope’s Gulden Mesara

    Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.

    By Nov. 2, 2022
  • Image attribution tooltip
    Leon Neal via Getty Images

    Vaccine chief’s exit spurs new slate of GSK executive changes

    How the pharma giant is consolidating power as it looks to become a dominant force in the vaccine market. 

    By Oct. 31, 2022
  • workplace culture
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    Pharma execs on creating a better workplace culture

    Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.

    By Oct. 28, 2022
  • Insomnia in healthcare
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    What’s keeping pharma leaders up at night

    C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.

    By Oct. 21, 2022
  • Image attribution tooltip
    Mario Tama via Getty Images

    J&J reveals just how much economic turbulence is affecting Big Pharma

    The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.

    By Oct. 20, 2022
  • Charlotte Deane BW headshot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Exscientia’s Charlotte Deane

    Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.

    By Oct. 19, 2022
  • Ryan Moslin, senior principal scientist, Bristol Myers Squibb
    Image attribution tooltip
    Permission granted by BMS / Ryan Moslin
    Q&A

    He helped discover BMS’s psoriasis pill Sotyktu. Here’s what he has to say about early science in Big Pharma

    Bristol Myers Squibb’s senior principal scientist Ryan Moslin shares why his team was built for success and how they ushered a potential psoriasis blockbuster through discovery.

    By Oct. 17, 2022
  • brand
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    What’s your leadership brand?

    Pharma industry leaders share their brand personas.

    By Oct. 14, 2022
  • A wooden figurine of a business person sits at a higher spot on a table than a series of six other wooden figurines of business people.
    Image attribution tooltip
    iStock via Getty Images
    Making Moves

    BIO’s interim CEO and Alvotech’s new chief quality officer could spell big changes for biotech

    What these life science organizations’ latest executive-level appointments mean for the industry.

    By Oct. 14, 2022
  • Subvariant virus spreading as viral pathogens
    Image attribution tooltip
    iStock via Getty Images
    Q&A // First 90 Days

    Coming out of stealth, RIGImmune aims to catch up with ever-mutating viruses

    President Susan Sobolov discusses how the startup is building on the work of two powerhouse Yale scientists to advance candidates for viruses — and beyond.

    By Kelly Bilodeau • Oct. 13, 2022
  • Ameet Mallik horizontal
    Image attribution tooltip
    Permission granted by Ameet Mallik
    Q&A

    Where the CEO of ADC Therapeutics sees ‘huge potential’ in the tech beyond oncology

    The “magic bullet” approach of ADCs has been a breakthrough in cancer care — but this excitement could be just the beginning.

    By Oct. 12, 2022